Ortho Regenerative Technologies Inc. announced the appointment of Mr. Michael Atkin as its new independent Chairman of the Board. Mr. Atkin is succeeding Mr. Steve Saviuk. Mr. Saviuk will continue to serve the company as a Board member. The change is effective immediately. Mr. Atkin is President of Syzent Partners Ltd. Mr. Atkin has over 30 years of experience in life sciences as an entrepreneur, start-up executive, leader and manager in the pharmaceutical and biotechnology industries, and in advancing early stage research towards commercialization based on satisfying unmet medical needs. Mr. Atkin serves on the board of a Université de Montréal spin-out company, Affinité Instruments, focused on laboratory and diagnostic tests.